Vaspin, a Compensatory Mechanism Against High Glucose Levels Since Birth?

Journal Title: Journal of Clinical Research in Pediatric Endocrinology - Year 2019, Vol 11, Issue 2

Abstract

Objective: Hormones produced by fat tissue, adipokines, produced during intrauterine life have recently been implicated in fetal growth. Vaspin is an adipokine expressed in visceral adipose tissue and has insulin-sensitizing effects. Elevated serum vaspin concentrations are associated with alterations in insulin sensitivity. We aimed to determine if vaspin concentrations in cord blood from healthy, term newborns differ among those born small for gestational age (SGA), appropriate for gestational age (AGA), and large for gestational age (LGA). A secondary objective was to determine whether an association existed between vaspin and anthropometric measurements, glucose and insulin levels in the newborn. Methods: The study population included healthy term newborns, 30 subjects in the SGA, 12 in the AGA, and 34 in the LGA group. Anthropometry was documented in all subjects. Blood was taken from the umbilical cord vein from each child for later analysis for vaspin, insulin and glucose concentrations. Results: Cord blood vaspin, insulin and glucose concentrations were not different between the three study groups. A negative correlation between vaspin and glucose concentrations was demonstrated in the whole cohort (r=-0.364, p=0.001). This correlation was also observed in the LGA group (r=-0.482, p=0.004). Glucose concentrations significantly predicted vaspin concentrations (r2=0.132, p=0.001). Conclusion: We found a negative association between glucose and vaspin concentrations in umbilical cord blood. In addition there was a predictive association between blood glucose and resulting vaspin concentration, suggesting that vaspin can be used as a predictor of alterations in the insulin-glucose metabolism from birth.

Authors and Affiliations

Citlalli E. Hernández-Rodríguez, Cynthia M. Estrada Zúñiga, Manuel E. De la O-Cavazos, Fernando F. Montes-Tapia, Patricia Gerez-Martínez, Fernando J. Lavalle-González, Consuelo Treviño Garza

Keywords

Related Articles

Metachronous Synovial Sarcoma After Treatment of Mixed Germ Cell Tumor in a Child with Complete Gonadal Dysgenesis

Patients with complete XY gonadal dysgenesis (GD) show a high predisposition to germ cell tumors (GCT). Patients with coexistence of GCT and GD have been reported previously. Here we present a 15-year-old girl with mixed...

Clinical and Genetic Findings of Turkish Hypophosphatasia Cases

Objective: Hypophosphatasia (HPP) is a rare, commonly unrecognized hereditary mineralization defect with a dramatically poor prognosis in severe cases. This study is the first to examine the detailed clinical and laborat...

High Prenatal Exposure to Bisphenol A Reduces Anogenital Distance in Healthy Male Newborns

Objective: To estimate the relationship between cord blood bisphenol A (BPA) levels and anogenital measurements in healthy newborns. Methods: Pregnancy and birth history, together with body mass and length data, anogeni...

The Evaluation of Cases with Y-Chromosome Gonadal Dysgenesis: Clinical Experience over 18 Years

Objective: Y-chromosome gonadal dysgenesis (GD) is a rare subgroup of disorders of sexual development (DSD) which results from underdeveloped testis and may exhibit heterogenous symptoms. These patients are phenotypicall...

Intrauterine Twin Discordancy and Partial Postnatal Catch-up Growth in a Girl with a Pathogenic IGF1R Mutation

Objective: Insulin like growth factors-1 (IGF-1) is essential for normal in utero and postnatal human growth. It mediates its effects through the IGF-1 receptor (IGF1R), a widely expressed cell surface tyrosine kinase re...

Download PDF file
  • EP ID EP581671
  • DOI 10.4274/jcrpe.galenos.2018.2018.0141
  • Views 179
  • Downloads 0

How To Cite

Citlalli E. Hernández-Rodríguez, Cynthia M. Estrada Zúñiga, Manuel E. De la O-Cavazos, Fernando F. Montes-Tapia, Patricia Gerez-Martínez, Fernando J. Lavalle-González, Consuelo Treviño Garza (2019). Vaspin, a Compensatory Mechanism Against High Glucose Levels Since Birth?. Journal of Clinical Research in Pediatric Endocrinology, 11(2), 125-131. https://europub.co.uk/articles/-A-581671